Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

39.02 +5.18 (+15.31%)

Streaming Delayed Price Updated: 2:38 PM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Cathie Wood's Ark Offloads $1.28M In Jack Dorsey's Block Shares Despite Bitcoin Rally ↗

October 15, 2024

On Tuesday, Cathie Wood-led Ark Invest made significant trades, most notably selling off shares of Block Inc. (NYSE:SQ). The SQ Trade

Via Benzinga

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,900 Today ↗

October 15, 2024

Via Benzinga

GSK Sues Moderna Alleging mRNA Vaccine Patent Infringement ↗

October 15, 2024

GlaxoSmithKline has filed a lawsuit against Moderna, claiming its mRNA vaccines infringe on GSK's patents. GSK seeks royalties for Moderna's alleged unlicensed use of its groundbreaking vaccine...

Via Benzinga

Topics Intellectual Property Lawsuit

Unveiling 18 Analyst Insights On Moderna ↗

October 15, 2024

Via Benzinga

The Bull's Biggest Hits And Misses ↗

October 14, 2024

The bull market turned two years old over the weekend. Here are some of the S&P 500's biggest winners and losers over the last two years.

Via Talk Markets

Topics Stocks

(MRNA) - Analyzing Moderna's Short Interest ↗

October 08, 2024

Via Benzinga

Abbas Hussain Joins Moderna's Board of Directors

October 02, 2024

Via ACCESSWIRE

Here's How Much $100 Invested In Moderna 5 Years Ago Would Be Worth Today ↗

September 24, 2024

Via Benzinga

Large-Cap Stocks In Trouble - Sunday, Oct. 13 ↗

October 13, 2024

Over the past 12 months, a group of 10 large-cap stocks have underperformed all others. Here’s an updated look at the top 10 worst performing large-caps, along with their one-year price returns.

Via Talk Markets

2 Biotech Stocks That Are Screaming Buys This Month ↗

October 12, 2024

They won't remain southbound forever.

Via The Motley Fool

Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table ↗

October 10, 2024

On Thursday Oct 10, 2024 Cathie Wood-Led Ark Invest sold over $9 million worth of Moderna stock.

Via Benzinga

Personalized Treatment And Immunotherapy Are Pharma's Newest Weapons Against Cancer ↗

October 10, 2024

On Sunday, The Guardian issued an article that spoke of a UK study that could transform how cancer is treated. The large-scale clinical project assessed how personalized cancer therapies could...

Via Benzinga

MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm

October 08, 2024

From The Schall Law Firm

Via Business Wire

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

October 08, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

October 07, 2024

Via Benzinga

Coinbase, Nike And Moderna Are Among Top 11 Large Cap Losers Last Week (Sept 30-Oct 4): Are The Others In Your Portfolio? ↗

October 06, 2024

Eleven large-cap stocks were worst performers last week. Decline in Stars performance and sales, regulations and supply issues caused the drop.

Via Benzinga

MRNA Deadline: Rosen Law Firm Urges Moderna, Inc. (NASDAQ: MRNA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights

October 05, 2024

From Rosen Law Firm

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

October 04, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer ↗

October 04, 2024

Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.

Via Investor's Business Daily

IMPORTANT MRNA DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

October 03, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

Alnylam's Concedes Its Patent Infringement Case Against Moderna's COVID-19 Vaccine ↗

October 03, 2024

Alnylam Pharmaceuticals has conceded that Moderna's products do not infringe on its patents, as a court ruling determined. Both companies have agreed to dismiss the case without prejudice for possible...

Via Benzinga

Topics Intellectual Property

Is It Time to Buy September's Worst-Performing S&P 500 Stocks? ↗

October 02, 2024

Could rebounds be in store for these beaten-down stocks?

Via The Motley Fool

Topics Stocks

The Covid Era Tech Promises To Reinvent Cancer Treatment ↗

October 01, 2024

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning to oncology for its next growth story.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 30, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines

September 30, 2024

Via ACCESSWIRE

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 30, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403

September 30, 2024

Via ACCESSWIRE

3 Surprisingly Underrated Stocks to Buy Right Now ↗

September 28, 2024

These stocks might look like bad picks. But appearances can be deceiving.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 25, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important October 8 Deadline in Securities Class Action – MRNA

September 24, 2024

From The Rosen Law Firm PA

Via GlobeNewswire

< Previous 1 2

...

23 24 25 26 27 28 29 30 31

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.